Muirwoods Ventures

Co-founder and Partner Yoon Choi leads investment decisions, drawing on his experience as a founding member of Samsung Ventures and subsequent role as Investment Director at SAIC Capital. He operates alongside Director Jehong Park, who handles execution for the investment team.

Muirwoods sources through its dual presence in Seoul and Silicon Valley and through institutional partnerships with Stanford’s Shorenstein APARC, where CEO Jennifer Jeong-Ah Ryou served as a visiting scholar, and the Ban Ki-moon Foundation. The firm also co-organizes the Trans-Pacific Sustainability Dialogue series, which brings together LPs, startups, and co-investors around shared sector themes.

Muirwoods operates as a venture capital firm rather than a traditional blind-pool fund, deploying capital through direct equity investments and co-investment partnerships. It does not publicly disclose a committed fund size, and its investment activity suggests a concentrated portfolio built around strategic co-investor relationships with entities like SIP Global Partners and Yamauchi No. 10 Family Office.

The firm concentrates on bio-healthcare, mobility, and IT. Within bio-healthcare, disclosed portfolio activity includes drug delivery platforms, antibody therapeutics, and medical devices. In mobility, known investments include autonomous vehicle technology through companies like Kodiak Robotics.

Through the Trans-Pacific Sustainability Dialogue, Muirwoods convenes policymakers, academics, and investors around technologies at the intersection of sustainability and venture. This forum doubles as a deal-flow pipeline and due-diligence network, allowing the firm to evaluate companies against institutional standards before committing capital.